BlackRock’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,197,501
| Closed | -$210K | – | 5655 |
|
|
2022
Q4 | $210K | Sell |
1,197,501
-390,426
| -25% | -$68.3K | ﹤0.01% | 4759 |
|
|
2022
Q3 | $688K | Buy |
1,587,927
+161,695
| +11% | +$70.1K | ﹤0.01% | 4536 |
|
|
2022
Q2 | $1.21M | Sell |
1,426,232
-2,080,337
| -59% | -$1.77M | ﹤0.01% | 4373 |
|
|
2022
Q1 | $19.3M | Buy |
3,506,569
+24,768
| +0.7% | +$136K | ﹤0.01% | 3120 |
|
|
2021
Q4 | $33.7M | Sell |
3,481,801
-2,679
| -0.1% | -$25.9K | ﹤0.01% | 2894 |
|
|
2021
Q3 | $62.3M | Buy |
3,484,480
+48,645
| +1% | +$870K | ﹤0.01% | 2486 |
|
|
2021
Q2 | $83.9M | Sell |
3,435,835
-201,782
| -6% | -$4.93M | ﹤0.01% | 2339 |
|
|
2021
Q1 | $96.4M | Buy |
3,637,617
+390,894
| +12% | +$10.4M | ﹤0.01% | 2193 |
|
|
2020
Q4 | $24.6M | Sell |
3,246,723
-40,704
| -1% | -$309K | ﹤0.01% | 2837 |
|
|
2020
Q3 | $16.5M | Sell |
3,287,427
-54,717
| -2% | -$274K | ﹤0.01% | 2899 |
|
|
2020
Q2 | $20M | Buy |
3,342,144
+324,154
| +11% | +$1.94M | ﹤0.01% | 2745 |
|
|
2020
Q1 | $13.4M | Sell |
3,017,990
-86,651
| -3% | -$386K | ﹤0.01% | 2786 |
|
|
2019
Q4 | $29.5M | Sell |
3,104,641
-73,451
| -2% | -$698K | ﹤0.01% | 2639 |
|
|
2019
Q3 | $25M | Buy |
3,178,092
+383,401
| +14% | +$3.01M | ﹤0.01% | 2668 |
|
|
2019
Q2 | $44M | Buy |
2,794,691
+130,641
| +5% | +$2.06M | ﹤0.01% | 2372 |
|
|
2019
Q1 | $48.2M | Buy |
2,664,050
+233,545
| +10% | +$4.23M | ﹤0.01% | 2285 |
|
|
2018
Q4 | $39.1M | Buy |
2,430,505
+840,707
| +53% | +$13.5M | ﹤0.01% | 2371 |
|
|
2018
Q3 | $38.2M | Buy |
+1,589,798
| New | +$38.2M | ﹤0.01% | 2509 |
|